Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | KDM5C | P41229 | 1/20 | 0.30 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.30 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1660805 | 0.86 | GRIK1 (0.32) | GRIK1ADH1BADH1CADH1ACYP2D6 | |
| SCHEMBL1659989 | 0.86 | ALDH1A1 (0.33) | GRIK1ADH1BADH1CADH1ACYP2D6 | |
| SCHEMBL1660839 | 0.84 | KDM4E (0.38) | GRIK1ADH1BADH1CADH1ACTSD | |
| SCHEMBL1661262 | 0.83 | KDM4E (0.52) | GRIK1CYP2D6CYP2C19CTSDKDM4E | |
| SCHEMBL1661038 | 0.81 | CTSD (0.40) | GRIK1CTSDKDM4EKDM5CPHF8 | |
| SCHEMBL1662968 | 0.79 | ALDH1A1 (0.47) | CYP2C19CTSDKDM4EKDM5CPHF8 | |
| SCHEMBL1661782 | 0.79 | KDM4E (0.43) | CYP2C19CTSDKDM4EKDM5CPHF8 | |
| SCHEMBL1660833 | 0.78 | ALDH1A1 (0.50) | CYP2C19CTSDKDM4EKDM5CPHF8 | |
| SCHEMBL1662977 | 0.78 | OGG1 (0.55) | CYP2D6CYP2C19KDM4E | |
| SCHEMBL1662970 | 0.78 | CTSD (0.63) | CYP2C19CTSDKDM4EKDM5CPHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-14 | — | — | US | claimed |
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | DOW AGROSCIENCES LLC (US) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086761-A1 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS | ERG28, DPM1, BROX | GRIK1 2583/4885ADH1B 3764/4885ADH1C 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.